EP 1677790 A1 20060712 - ALKYNES II
Title (en)
ALKYNES II
Title (de)
ALKYNE II
Title (fr)
ALKYNES II
Publication
Application
Priority
- US 2004034519 W 20041020
- US 56071403 P 20031031
- US 56071303 P 20031031
Abstract (en)
[origin: WO2005044267A1] The present invention is directed to novel compounds of formula (I), to a process for their preparation, their use and pharmaceutical compositions comprising the novel compounds. The novel compounds are useful in therapy, and in particular for the treatment of gastroesophageal reflux disease (GERD).
IPC 1-7
A61K 31/44; C07D 213/30; C07D 213/32; C07D 213/38; A61P 1/04
IPC 8 full level
C07D 213/14 (2006.01); C07D 213/30 (2006.01); C07D 213/32 (2006.01); C07D 213/38 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 21/00 (2017.12); C07D 213/14 (2013.01); C07D 213/30 (2013.01); C07D 213/32 (2013.01); C07D 213/38 (2013.01)
Citation (search report)
See references of WO 2005044267A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005044267 A1 20050519; CA 2549969 A1 20050519; EP 1677790 A1 20060712; JP 2007509935 A 20070419
DOCDB simple family (application)
US 2004034519 W 20041020; CA 2549969 A 20041020; EP 04795655 A 20041020; JP 2006538085 A 20041020